Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Top Biotech Stocks to Buy Right Now


It's been a rough year for the biotech industry, which as a whole has substantially lagged the broader market. Just look at the performance of the SPDR S&P Biotech ETF, an industry benchmark. What's more, some biotechs have been encountering their own company-specific issues.

Two worth a closer look today are Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA) whose prospects really don't look as bad as their year-to-date performances suggest. At current levels, both Amgen and Moderna are worth investing in now. Let's find out why.

AMGN Chart

Continue reading


Source Fool.com

Amgen Inc. Stock

€367.95
0.140%
Amgen Inc. gained 0.140% compared to yesterday.
The stock is one of the favorites of our community with 42 Buy predictions and 4 Sell predictions.
On the other hand, the target price of 343 € is below the current price of 367.95 € for Amgen Inc., so the potential is actually -6.78%.
Like: 0
Share

Comments